Home FOXL2 mutations in Taiwanese patients with blepharophimosis, ptosis, epicanthus inversus syndrome
Article
Licensed
Unlicensed Requires Authentication

FOXL2 mutations in Taiwanese patients with blepharophimosis, ptosis, epicanthus inversus syndrome

  • Wei-De Lin , I-Ching Chou , Ni-Chung Lee , Chung-Hsing Wang , Wuh-Liang Hwu , Shuan-Pei Lin , Mei-Chyn Chao , Yushin Tsai and Fuu-Jen Tsai
Published/Copyright: February 26, 2010

Abstract

Background: Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES) is an autosomal dominant developmental disorder that includes an eyelid malformation associated with (type I) or without (type II) premature ovarian failure (POF). Mutations in the forkhead transcription factor 2 (FOXL2) gene, a member of winged/forkhead transcription factor family, are responsible for both types of BPES. The purpose of this study was to identify mutations in FOXL2 in Taiwanese patients with BPES.

Methods: The karyotype and genomic DNA was prepared from the leukocytes of peripheral venous blood samples. The coding and flanking region sequences of FOXL2 were analyzed by directed or cloning sequencing.

Results: The karyotypes of these patients did not show significant variation, especially on the 3q23 region. Two mutations in FOXL2 were identified in two familial cases. One was c.855-871dup (17-bp insertion) associated with POF. The other was c.384G>A (TGG>TGA), a novel mutation that resulted in non-sense changes of the encoded protein, i.e., p.W128X.

Conclusions: Our results expand the spectrum of FOXL2 mutations and confirm the mutation hotspot in FOXL2 in Taiwanese BPES patients.

Clin Chem Lab Med 2010;48:485–8.


Corresponding author: Dr. Fuu-Jen Tsai, Department of Pediatrics and Medical Genetics, China Medical University Hospital, 2, Yuh Der Road, 404, Taichung, Taiwan Tel.: +886-4-22052121 ext. 2041, Fax: +886-4-22033295,

Received: 2009-10-8
Accepted: 2009-12-4
Published Online: 2010-02-26
Published in Print: 2010-04-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorials
  2. Molecular biology and genetics in clinical chemistry and laboratory medicine
  3. Improving the post-analytical phase
  4. Reviews
  5. State of the art in therapeutic drug monitoring
  6. Decision criteria for rational selection of homogeneous genotyping platforms for pharmacogenomics testing in clinical diagnostics
  7. Reference Values and Biological Variations
  8. Assessment of critical values policies in Italian institutions: comparison with the US situation
  9. Genetics and Molecular Diagnostics
  10. Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping
  11. Genotyping mitochondrial DNA single nucleotide polymorphisms by PCR ligase detection reactions
  12. FOXL2 mutations in Taiwanese patients with blepharophimosis, ptosis, epicanthus inversus syndrome
  13. Low expression of human β-defensin 1 in duodenum of celiac patients is partially restored by a gluten-free diet
  14. General Clinical Chemistry and Laboratory Medicine
  15. Evaluation of C-reactive protein and serum amyloid A in the detection of inflammatory and infectious diseases in children
  16. Procalcitonin measurement in routine emergency medicine practice: comparison between two immunoassays
  17. Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer
  18. Simultaneous determination of serum tryptophan metabolites in patients with systemic lupus erythematosus by high performance liquid chromatography with fluorescence detection
  19. Beware of carryover in modern chemistry analyzers
  20. Correlation between glucose and bupivacaine levels in cerebrospinal fluid after spinal anesthesia: glycorrhachia as predictor for duration of sensory block
  21. Comparison of different depletion strategies for improving resolution of the human urine proteome
  22. Cardiovascular Diseases
  23. Pregnancy-associated plasma protein-A as a marker for long-term mortality in patients with peripheral atherosclerosis: inconclusive findings from the Linz Peripheral Arterial Disease (LIPAD) study
  24. Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentrations in Taiwanese individuals
  25. C-reactive protein variants are not associated with susceptibility to stroke and stroke recurrence
  26. Association of hyperhomocysteinemia with left ventricular dilatation and mass in human heart
  27. A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays
  28. Letters to the Editor
  29. High specificity but low sensitivity of the cartilage oligomeric matrix protein (COMP) test in rheumatoid arthritis and osteoarthritis
  30. Disparity in estimated average glucose due to different hemoglobin A1c methods and hemoglobin S trait
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.100/pdf
Scroll to top button